A coalition of 18 pharma companies located in India, China, Bangladesh and South Africa that manufacture generic drugs have pledged to work together to accelerate access to millions of doses of new interventions for COVID-19 for low- and middle-income countries. A coalition of 18 pharma companies located in India, China, Bangladesh and South Africa that … Continue reading Eight Indian generic drug companies join international coalition, pledge to make COVID-19 drugs
Lupin
‘Child-friendly paediatric TB drugs will be a game changer’
Treating young children afflicted with drug-sensitive TB disease will no longer be the same. After years of neglect, the availability of flavoured, easily dissolvable first-line TB drugs in correct doses marks a watershed moment as the special needs of these children will be met. The tablets, which are a combination of two and more medicines … Continue reading ‘Child-friendly paediatric TB drugs will be a game changer’
Child-friendly, first-line TB combination drugs will be available in 2016: Dr. Mel Spigelman
Dr. Mel Spigelman, President and Chief Executive Officer of the Global Alliance for TB Drug Development (TB Alliance) is regarded as one of the world’s leading experts in tuberculosis and TB drug development. He was instrumental in forging key organisational partnerships and building the pipeline of TB drug candidates when he was the Director of … Continue reading Child-friendly, first-line TB combination drugs will be available in 2016: Dr. Mel Spigelman
Science Chronicle 